Scott Jeffers, PhD, the chief technology officer at GenSight Biologics, discussed using Verdot’s FlexiPro system to produce Lumevoq gene therapy.
Scott Jeffers, PhD
Advertisement
Articles by Scott Jeffers, PhD
The chief technology officer at GenSight Biologics discussed using Verdot’s FlexiPro system to produce Lumevoq gene therapy.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Naji Gehchan, MD, MBA, on Evaluating CAR-T KYV-101 for Generalized Myasthenia Gravis
2
Quarter Century Update: Thoughts on Reducing Costs of Goods
3
CGTLive®’s Weekly Rewind – October 31, 2025
4
Quarter Century Update: Future Predictions for the Field
5
